162 related articles for article (PubMed ID: 35885462)
1. Automated Detection of Dysplasia: Data Mining from Our Hematology Analyzers.
Zhu J; Clauser S; Freynet N; Bardet V
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885462
[TBL] [Abstract][Full Text] [Related]
2. Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratory.
Zhu J; Lemaire P; Mathis S; Ronez E; Clauser S; Jondeau K; Fenaux P; Adès L; Bardet V
BMC Cancer; 2022 Sep; 22(1):972. PubMed ID: 36088307
[TBL] [Abstract][Full Text] [Related]
3. Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia.
Hwang SM; Nam Y
Int J Lab Hematol; 2022 Jun; 44(3):468-476. PubMed ID: 34877795
[TBL] [Abstract][Full Text] [Related]
4. Laboratory productivity and the rate of manual peripheral blood smear review: a College of American Pathologists Q-Probes study of 95,141 complete blood count determinations performed in 263 institutions.
Novis DA; Walsh M; Wilkinson D; St Louis M; Ben-Ezra J
Arch Pathol Lab Med; 2006 May; 130(5):596-601. PubMed ID: 16683868
[TBL] [Abstract][Full Text] [Related]
5. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
6. Beyond the In-Practice CBC: The Research CBC Parameters-Driven Machine Learning Predictive Modeling for Early Differentiation among Leukemias.
Haider RZ; Ujjan IU; Khan NA; Urrechaga E; Shamsi TS
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054304
[TBL] [Abstract][Full Text] [Related]
7. Determination of acute leukemia lineage with new morphologic parameters available in the complete blood cell count.
Yang JH; Kim Y; Lim J; Kim M; Oh EJ; Lee HK; Park YJ; Min WS; Cho B; Lee K; Han K
Ann Clin Lab Sci; 2014; 44(1):19-26. PubMed ID: 24695469
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood film review. The demise of the eyecount leukocyte differential.
Pierre RV
Clin Lab Med; 2002 Mar; 22(1):279-97. PubMed ID: 11933579
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Leucocyte Cell Population Data by Sysmex XN1000 Hematology Analyzer in Rapid Identification of Acute Leukemia.
Mishra S; Chhabra G; Padhi S; Mohapatra S; Panigrahi A; Sable MN; Das PK
Indian J Hematol Blood Transfus; 2022 Jul; 38(3):499-507. PubMed ID: 35747581
[TBL] [Abstract][Full Text] [Related]
10. The Mesenchymal Niche in Myelodysplastic Syndromes.
Friedrich C; Kosmider O
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885544
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of the latest fully automated hematology analyzers in a large, commercial laboratory setting: a 4-way, side-by-side study.
Bourner G; Dhaliwal J; Sumner J
Lab Hematol; 2005; 11(4):285-97. PubMed ID: 16475476
[TBL] [Abstract][Full Text] [Related]
12. Research use only and cell population data items obtained from the Beckman Coulter DxH800 automated hematology analyzer are useful in discriminating MDS patients from those with cytopenia without MDS.
Park SH; Kim HK; Jeong J; Lee SH; Lee YJ; Kim YJ; Jo JC; Lim JH
J Hematop; 2023 Sep; 16(3):143-154. PubMed ID: 38175401
[TBL] [Abstract][Full Text] [Related]
13. MDS overlap disorders and diagnostic boundaries.
Tanaka TN; Bejar R
Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
[TBL] [Abstract][Full Text] [Related]
14. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
Tang G; Medeiros LJ; Wang SA
Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
[TBL] [Abstract][Full Text] [Related]
15. Discriminating myelodysplastic syndrome and other myeloid malignancies from non-clonal disorders by multiparametric analysis of automated cell data.
Kim SY; Park Y; Kim H; Kim J; Kwon GC; Koo SH
Clin Chim Acta; 2018 May; 480():56-64. PubMed ID: 29378171
[TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of leukocyte differential on the hematology analyzer Celltac G compared with two hematology analyzers, reference flow cytometry method, and two manual methods.
Yamade K; Yamaguchi T; Nagai Y; Kamisako T
J Clin Lab Anal; 2021 Aug; 35(8):e23827. PubMed ID: 34117659
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of a hematology blood counter with five-part leukocyte differential capability.
Davis BH; Bigelow NC
Am Clin Lab; 1999; 18(10):8-9. PubMed ID: 10848432
[TBL] [Abstract][Full Text] [Related]
18. Rapid screening of dengue fever using research parameters from new generation hematological analyzers.
Chhabra G; Das B; Mishra S; Mishra B
Int J Lab Hematol; 2022 Jun; 44(3):477-482. PubMed ID: 34935292
[TBL] [Abstract][Full Text] [Related]
19. Comparison of abnormal cell flagging of the hematology analyzers Sysmex XN and Sysmex XE-5000 in oncohematologic patients.
Furundarena JR; Sainz M; Uranga A; Cuevas L; Lopez I; Zubicaray J; Bizjak A; Robado N; Araiz M
Int J Lab Hematol; 2017 Feb; 39(1):58-67. PubMed ID: 27981789
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in myelodysplastic syndromes.
Triantafyllidis I; Ciobanu A; Stanca O; Lupu AR
Maedica (Bucur); 2012 Dec; 7(4):295-302. PubMed ID: 23483702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
